Clinical and dosimetric predictors of radiation-induced esophageal toxicity

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 1, 1999, Pages 97-103

  Maguire, Patrick D ^a   Sibley, Gregory S ^a   Zhou, Su Min ^a   Jamieson, Timothy A ^a   Light, Kim L ^a   Antoine, Phillip A ^a   Herndon II, James E ^a   Anscher, Mitchell S ^a   Marks, Lawrence B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Conformal radiation therapy; Dose volume histogram; Esophageal; Morbidity; Nonsmall cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; NAVELBINE; PACLITAXEL;

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; DOSIMETRY; DYSPHAGIA; ESOPHAGITIS; ESOPHAGUS INJURY; FEMALE; HISTOGRAM; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; CHRONIC DISEASE; DEGLUTITION DISORDERS; ESOPHAGEAL DISEASES; ESOPHAGITIS; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 0032813864     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00163-7     Document Type: Article

References (20)

1. Lyman J.T. Complication probability as assessed from dose volume histograms. Radiat Res. 8:(Suppl. 1):1995;513-519.
2. Kutcher G.J., Burman C., Brewster L., et al. Calculation of complication probability factors for nonuniform tissue irradiation The effective volume method . Int J Radiat Oncol Biol Phys. 16:1989;1623-1630.
3. Zhou S.M., Sibley G.S., Maguire P.D., et al. A new method to display three-dimensional dose distributions for tubular organs. (Abstr.) Int J Radiat Oncol Biol Phys. 42:(Suppl. 1):1998;376.
4. Northway M.G., Libshitz H.I., West J.J., et al. The opposum as an animal model for studying radiation esophagitis. Radiology. 131:1979;731-735.
5. Phillips T.L., Ross G. Time-dose relationships in the mouse esophagus. Radiology. 113:1974;435-440.
6. Michalowski A., Hornsey S. Assays of damage to the alimentary canal. Br J Cancer. 7:(Suppl. 1):1986;1-6.
7. Goldstein H., Rogers L., Fletcher G., et al. Radiological manifestations of radiation-induced injury to the normal upper gastrointestinal tract. Radiology. 117:1975;135-140.
8. Lepke R., Libshitz H. Radiation-induced injury of the esophagus. Radiology. 148:1983;375-378.
9. Seaman W.B., Ackerman L.V. The effect of radiation on the esophagus. Radiology. 68:1957;534-540.
10. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21:1991;109-122.
11. Cox J.D., Azarnia N., Byhardt R.W., et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79. 2 Gy: Possible survival benefit with ≥69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol. 8:1990;1543-1555.
12. Saunders M., Dische S., Barrett A., et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer A randomised multicentre trial . Lancet. 350:1997;161.
13. Greco F.A., Brereton H.D., Kent H., et al. Adriamycin and enhanced radiation reaction in normal esophagus and skin. Ann Intern Med. 85:1976;294-298.
14. Newberger P.E., Cassady J.R., Jaffe N. Esophagitis due to adriamycin and radiation therapy for childhood malignancy. Cancer. 42:1978;417-423.
15. Boal D.K., Newberger P.E., Teele R.L. Esophagitis induced by combination radiation and adriamycin. AJR. 132:1979;567-570.
16. Umsawasdi T., Valdevieso M.V., Barkley T., et al. Esophageal complications from combined chemoradiotherapy (cyclophosphamide + adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 11:1984;511-519.
17. Langer C.J., Movsas B., Hudes R., et al. , induction paclitaxel and carboplatin followed by concurrent chemoradiation in patients with unresectable, locally advanced non-small cell lung cancer Report of Fox Chase Cancer Center Study 94-001 . Sem Oncol. 4:(Suppl. 12):1997;89-95.
18. Dillman R.O., Seagren S.L., Propert K.L., et al. A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med. 323:1990;940-945.
19. Sause W.T., Scott C., Taylor S., et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588 Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer . J Natl Cancer Inst. 82:1995;198-205.
20. Marks L.B., Munley M.T., Spencer D.P., et al. Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys. 38:1997;399-409.